A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Recruiting
N/A
Interventional Study
Ductal Carcinoma in Situ
Stage I Breast Cancer
Stage II Breast Cancer
Stage III Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Barbara Ann Karmanos Cancer Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if tattoos applied with Magic Ink is as safe as commercially available standard tattoo ink for the purpose of radiation in women with breast cancer undergoing radiation treatment. The main questions are:
* Is the Magic Ink as safe as standard tattoo ink
* Does Magic Ink continue to function and remain visible for radiation therapists during the treatmen…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participant must have histologically or cytologically confirmed stage 0 ductal carcinoma in situ (DCIS), I, II or III breast cancer and be planning to undergo radiation therapy (RT) after surgery
* Participants must be 18 years of age or older
* Participant must be able to und…
Contacts